Clinical Trials
5 trialsNCT05645107 2026-04-13
EXCELL
Grifols Therapeutics LLC
Phase 3 Recruiting
NCT05493800 2024-05-29
Capella
MitoImmune Therapeutics
Phase 2 Unknown
NCT04571645 2024-04-15
AML
Jazz Pharmaceuticals
Phase 3 Terminated
NCT02663622 2024-01-23
MK-7110-002
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Completed
NCT01687387 2019-02-08
EFFIKIR
Innate Pharma
Phase 2 Completed